Objective We plan to carry out a valorisation project for a series of novel small molecule inhibitors of Factor Inhibiting HIF (FIH) that we have developed for the treatment of lung cancer, as a next-generation therapeutic approach in the field of immuno-oncology.The valorisation plan will include: clarification of IP rights and strategy, establishing contacts with potential investors and pharma partners, and verification of the potential of start-up creation. Moreover, valorisation activities will include progression of hits against FIH into a lead optimisation campaign with the aim of designating a candidate drug. Fields of science medical and health sciencesclinical medicineoncologylung cancermedical and health sciencesbasic medicineimmunologyimmunotherapy Programme(s) HORIZON.1.1 - European Research Council (ERC) Main Programme Topic(s) ERC-2022-POC1 - ERC PROOF OF CONCEPT GRANTS1 Call for proposal ERC-2022-POC1 See other projects for this call Funding Scheme HORIZON-AG-LS - HORIZON Lump Sum Grant Coordinator ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS Net EU contribution € 150 000,00 Address Parque tecnologico edificio 801 a 48160 Derio vizcaya Spain See on map Region Noreste País Vasco Bizkaia Activity type Research Organisations Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00
